| Literature DB >> 30718753 |
Daisuke Kasai1, Takumi Iwasaki2, Kazuki Nagai3, Naoto Araki3, Tatsunari Nishi2, Masao Fukuda3,4.
Abstract
Pseudomonas sp. strain PTH10 can utilize o-phthalate which is a key intermediate in the bacterial degradation of some polycyclic aromatic hydrocarbons. In this strain, o-phthalate is degraded to 2,3-dihydroxybenzoate and further metabolized via the 2,3-dihydroxybenzoate meta-cleavage pathway. Here, the opa genes which are involved in the o-phthalate catabolism were identified. Based on the enzymatic activity of the opa gene products, opaAaAbAcAd, opaB, opaC, and opaD were found to code for o-phthalate 2,3-dioxygenase, dihydrodiol dehydrogenase, 2,3-dihydroxybenzoate 3,4-dioxygenase, and 3-carboxy-2-hydroxymuconate-6-semialdehyde decarboxylase, respectively. Collectively, these enzymes are thought to catalyze the conversion of o-phthalate to 2-hydroxymuconate-6-semialdehyde. Deletion mutants of the above opa genes indicated that their products were required for the utilization of o-phthalate. Transcriptional analysis showed that the opa genes were organized in the same transcriptional unit. Quantitative analysis of opaAa, opaB, opaC, opaD, opaE, and opaN revealed that, except for opaB and opaC, all other genes were transcriptionally induced during growth on o-phthalate. The constitutive expression of opaB and opaC, and the transcriptional induction of opaD located downstream of opaB, suggest several possible internal promoters are existence in the opa cluster. Together, these results strongly suggest that the opa genes are involved in a novel o-phthalate catabolic pathway in strain PTH10.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30718753 PMCID: PMC6362003 DOI: 10.1038/s41598-018-38077-2
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Characteristics of opa genes.
| Gene | Deduced molecular mass (Da)a | Representative homolog | Identity (%)b | Accession no. |
|---|---|---|---|---|
|
| 48,985 | Anthranilate 1,2-dioxygenase large subunit (AntA) from | 30 | AAC34813 |
| (433) | Benzoate 1,2-dioxygenase large subunit (BenA) from | 30 | AAC46436 | |
|
| 19,403 | Anthranilate 1,2-dioxygenase small subunit (AntB) from | 27 | AAC34814 |
| (171) | Benzoate 1,2-dioxygenase small subunit (BenB) from | 26 | AAC46437 | |
|
| 11,911 | Carbazole 1,9a-dioxygenase ferredoxin component (CarAc) from | 47 | BAA21733 |
| (110) | Anthranilate 1,2-dioxygenase ferredoxin component (AndAb) from | 36 | AAO83641 | |
|
| 36,575 | Acenaphthene dioxygenase ferredoxin reductase component (ArhA4) from | 46 | BAE93942 |
| (337) | Carbazole 1,9a-dioxygenase ferredoxin reductase component (CarAd) from | 42 | BAA21735 | |
|
| 29,067 | Benzoate diol dehydrogenase (BenD) from | 50 | AAC46439 |
| (269) | 1,2-Dihydroxycyclohexa-3,4-diene carboxylate dehydrogenase (XylL) from | 49 | AAA26050 | |
|
| 32,431 | DBA 3,4-dioxygenase (DhbA) from | 55 | AFN52421 |
| (285) | 2,3-Dihydroxy- | 51 | BAA82122 | |
|
| 36,819 | 2-Amino-3-carboxymuconate 6-semialdehyde decarboxylase (NbaD) from | 30 | BAC65312 |
| (327) | 5-Carboxy-2-hydroxymuconate-6-semialdehyde decarboxylase (PraH) from | 28 | BAH79106 | |
|
| 52,750 | HMS dehydrogenase (NahI) from | 75 | BAE92168 |
| (486) | HMS dehydrogenase (XylG) from | 71 | AAA26053 | |
|
| 7,356 | OCA tautomerase (DhbF) from | 44 | AFN52426 |
| (66) | OCA tautomerase (DmpI) from | 38 | CAA43229 | |
|
| 28,313 | OCA decarboxylase (DmpH) from | 89 | CAA43228 |
| (264) | OCA decarboxylase (XylI) from | 87 | AAA25693 | |
|
| 30,679 | HMS hydrolase (DmpD) from | 66 | CAA36993 |
| (276) | HMS hydrolase (DhbI) from | 59 | AFN52439 | |
|
| 27,888 | HPD hydratase (XylJ) from | 71 | AAA26055 |
| (261) | HPD hydratase (DhbD) from | 63 | AFN52424 | |
|
| 37,358 | HOV aldolase (DhbH) from | 89 | AFN52428 |
| (345) | HOV aldolase (XylK) from | 87 | AAA25692 | |
|
| 32,998 | Acetaldehyde dehydrogenase (DhbG) from | 76 | AFN52427 |
| (312) | Acetaldehyde dehydrogenase from (NbaJ) from | 68 | BAC65307 | |
|
| 37,594 | TRAP transporter solute receptor from | 29 | CDQ31851 |
| (349) | Putative periplasmic binding protein from | 27 | CAI10584 | |
|
| 44,696 | Phosphate-selective porin from | 61 | EKE36862 |
| (412) | Phosphate-selective porin from | 33 | EEF79304 | |
|
| 70,229 | TRAP transporter from | 38 | AEI95128 |
| (660) | TRAP transporter from | 33 | GAE27593 | |
|
| 32,346 | Hypothetical protein from | 29 | EHB57276 |
| (300) | Hypothetical protein from | 28 | ADD06240 |
aThe values in parentheses are the numbers of amino acid residues.
bPercentages of identity by aligning the deduced amino acid sequences by use of EMBOSS alignment tool.
Figure 1The OPA catabolic pathway genes in Pseudomonas sp. strain PTH10. (a) Open arrows indicate the sizes, locations, and transcriptional directions of ORFs. The deletion regions of the mutants are indicated by gray boxes above the gene cluster diagram. Boldface bars below the gene cluster diagram indicate the locations of the amplified RT-PCR products shown in panel (c). (b) OpaAaAb, large and small subunits, respectively, of oxygenase component of OPA 2,3-dioxygenase; OpaAc, ferredoxin component of OPA 2,3-dioxygenase; OpaAd, ferredoxin reductase component of OPA 2,3-dioxygenase; OpaB, dihydrodiol dehydrogenase; OpaC, 23DHBA 3,4-dioxygenase; OpaD, CHMS decarboxylase; OpaE, HMS dehydrogenase; OpaF, OCA tautomerase; OpaG, OCA decarboxylase; OpaH, HMS hydrolase; OpaI, HPD hydratase; OpaJ, HOV aldolase; and OpaK, acetaldehyde dehydrogenase (acylating). (c) The results of agarose gel electrophoresis of RT-PCR products obtained with primers targeting RT1 (expected size 2,865 bp), RT2 (expected size 2,501 bp), RT3 (expected size 2,039 bp), RT4 (expected size 2,100 bp), RT5 (expected size 3,054 bp), RT6 (expected size 2,367 bp), and RT7 (expected size 2,124 bp) are shown. The amplified regions and the primer sequences are indicated in panel (a) and Table S1, respectively. Lanes M, molecular size markers; lanes G, control PCR with the genomic DNA of strain PTH10; lanes + and −, RT-PCR with and without RT, respectively. Because, the image of the gel was cropped, full-length gel image is presented in Supplementary Fig. S4.
Figure 2Growth of strain PTH10 and its mutant derivatives on OPA. (a) PTH10 (closed circles), DOA (open squares), DOB (open diamonds), DOC (open triangles), and DOD (open circles). (b) PTH10 (closed circles), opaAa-complementated DOA (open squares), opaB-complementated DOB (open diamonds), opaC-complementated DOC (open triangles), and opaD-complementated DOD (open circles). These strains were grown in W medium containing 10 mM OPA. The data are averages ± standard deviations of three independent experiments performed in parallel.
Figure 3Degradation of OPA by strain PTH10 and its mutant derivatives. The cells of PTH10 (closed circles), DOA (open squares), DOB (open diamonds), opaAa-complementated DOA (closed squares), and opaB-complementated DOB (closed diamonds) were incubated with 100 μM OPA. The remaining amount of each substrate was determined by HPLC analysis. The values represent the averages ± standard deviations of three independent experiments.
Figure 4Conversion of 23DHBA by strain PTH10 and its mutant derivative. The reaction mixtures containing 100 μM 23DHBA and the cells of PTH10 (a) and DOD (b) were incubated at 30 °C. UV-visible spectra were recorded at the start, after 3, and 6 hours of incubation, which are represented by the solid, dashed, and dotted lines, respectively.
Figure 5Quantification of the expression levels of the opa genes. Total RNA was isolated from the cells of PTH10 grown in W medium containing 10 mM succinate (open bars) or 10 mM OPA (grey bars). The mRNA expression levels were calculated as a ratio of 16S rRNA gene expression. The data are mean values ± standard deviations for three independent experiments. N.D.: Not detected.